ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Trial details
- Registry ID
- NCT07531745
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet SyndromeNCT07531745 | IONS | Phase 1, Phase 2 | Recruiting | 2030-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |